Imodium

Loperamide, the active ingredient in Imodium, is a peripheral opioid receptor agonist presented as an oral formulation for oral use. It treats acute nonspecific diarrhea and traveler’s diarrhea in adults and children.

GNH USA supplies Imodium as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium acts on the gastrointestinal motility pathway to control diarrheal conditions.

Acute nonspecific diarrhea: reduces stool frequency and liquidity, providing symptomatic relief. Traveler's diarrhea: alleviates loose‑stool symptoms and helps shorten the duration of illness.

Adverse reactions may range from mild to severe and should be monitored.

Common Side Effects: - Constipation - Abdominal cramps - Nausea - Dry mouth - Drowsiness - Dizziness

Serious or Rare Side Effects: - Severe constipation or bowel obstruction - Ileus or toxic megacolon - Allergic reactions such as rash or angioedema - Cardiac arrhythmia (QT prolongation) - Severe skin reactions (Stevens‑Johnson syndrome) - Hepatotoxicity in rare cases

Use Imodium according to professional guidance and consider the following safety points.

Do not exceed recommended dose: follow prescriber or label instructions. Use caution in hepatic impairment: reduced metabolism may increase exposure. Avoid in children under 2 years: risk of serious side effects. Do not use in bacterial enterocolitis without physician direction: may worsen infection. Discontinue if severe constipation develops: seek medical advice. Store below 25°C: keep in the original pack, protect from moisture.

Loperamide may interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise loperamide levels. - Other opioid agonists: additive central effects may increase risk of respiratory depression. - MAO inhibitors: may potentiate opioid‑related effects. - P-glycoprotein inhibitors (e.g., quinidine): increase systemic exposure. - Anticholinergic agents: can exacerbate constipation.

Moderate Interactions (Monitor Closely): - Antidiarrheal combinations: may cause excessive slowing of gut motility. - Antihistamines: may enhance drowsiness. - Diuretics: monitor electrolyte balance if severe constipation occurs. - NSAIDs: watch for gastrointestinal irritation. - Herbal supplements affecting CYP enzymes: adjust monitoring as needed.